chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My symptoms started with waking up in the morning with left arm middle finger that would not straighten and was in a bent position. It was very painful to try to straighten. I went to an orthopedic doctor and was diagnosis with trigger finger and was treated like arthritis. I was given some exercises to do. 2 months later, this happened again on my right arm ring finger. I am going to an occupational therapist. I now wear a splint. I am trying occupational therapy before going on steroids. Also, had COVID-19 in January, 2022 with positive test. Symptoms included runny nose, fever, cough. That lasted for 1 week.
Narrative:  COVID infection following COVID vaccine series 02/09, Pfizer, dose #1 03/02, Pfizer, dose #2 10/14, Pfizer, dose #3 11/08 COVID swab, result: detected 11/07 pt cc: cough, fatigue, fever, headache, loss of taste or smell, myalgias, dyspnea exposure: unknown 11/08 SARS-COV-2 Variant Sequencing result: pending 11/17 clinically resolved
This spontaneous report as received from a nurse practitioner refers to an unspecified patient of unknown age and gender. On an unkonwn date two pediatric doses of VAQTA (dose, lot# expiry date and indication were not reported), were administered to unspecified adult patient rather than one adult dose of VAQTA. No adverse effect was reported. Additional information has been requested.
Swollen Lymph Nodes; This is a spontaneous report from a contactable consumer. A20-year-male consumer received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (Batch/lot number: EL1284 ) via an unspecified route of administration, on 07Jan2021 14:00 at a single dose, for COVID-19 immunization. Facility type vaccine: Military Base. Anatomical Location: Arm Left. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No patient's medical history reporter and concomitant medication included creatine monohydrate (CREATINE MONOHYDRATE). The patient experienced swollen lymph nodes on 07Jan2021 19:00 with outcome of not recovered.  he action taken was not applicable. No treatment was received.
6 days p/vax started having coughing w/sputum production, real bad head congestion, nasal stuffiness, runny nose, & h/a;
I went to pharmacy to get my yearly flu shot for work. As I left the store I felt head-achy and slightly light headed. On my drive home the head ache got worse and body aches developed. By the time I got home (about 20 min.after the vaccine) I felt feverish and fatigued. I did not take my temperature because i could not find the thermometer. As I looked for the thermometer I noticed I had hives on my arms and chest. later that afternoon I noticed my eyes were puffy and a numb/dry mouth sensation so I took Benadryl. The next day the Hives and puffiness were gone. I took my vaccine confirmation to work. The Nurse practitioner on site suggested that I file a Vaers report.
Presented with fever, SOB, rash and pain in left arm. Treated with BENADRYL 25mg-IM and Decadron 4mg IM. Placed on O2/2L. Also had tingling in hands and feet. Fever.
Please see mother's detailed history. Attached also ER & allergist note re: event. Pt received his Dtap immunization on Tuesday, May 10, 2011 at approximately 5:00 pm. After the shot was administered the following symptoms and side effects occurred: Wednesday, May 11, 2011 - pt complained of a headache, I gave him acetaminophen for the pain. Thursday, May 12, 2011 - pt woke up early Thursday having an asthma attack. I administered PRO-AIR to support his breathing. Thursday, May 13, 2011 - pt began to get hives of varying sizes, but some hives were approximately the size of oranges on his torso and extremities. I took patient to pediatric office so you could see the hives and check his TB test. After seeing you, patient's condition continued to worsen, so I consulted the allergist, and he suggested I start ZYRTEC qd. You follow-up via phone on Thursday night to see how patient was doing. At this time, I let you know that his condition worsened and that I was very concerned that patient's reaction was from the Dtap vaccination. He has not had a reaction like this since his allergies have been under control, and nothing new was introduced in his daily routine. At this time, you did not want me to think patient's reaction was from the vaccine but some other source. Friday, May 13, 2011 - patient woke up again early Friday morning having an asthma attack. I administered PRO-AIR to support his breathing. Friday morning the hives had subsided but were still present, and by Friday evening, the hives had exhibited themselves again more aggressively. We continued to administer BENADRYL and ZYRTEC. Saturday, May 14, patient woke up again approximately 12:30 am with another asthma attack, more severe than the others, and I administered PRO-AIR to support his breathing. When patient woke up Saturday morning, he was covered, torso, face and limbs, with hives so severe and aggressive that his face was swollen and he was unrecognizable. At this time, I called the pediatric, on call line, and doctor suggested we take patient to the ER. I took patient to the ER and the doctor confirmed that he was having an allergic reaction and prescribed prednisolone bid and a regiment to also include BENADRYL and ZYRTEC. In addition, the doctor told me to follow up with the pediatrician and allergist; therefore, after the ER visit I went directly to the allergist so that the doctor could see the condition and severity of patient's hives and reaction.
chills; body aches; constant nausea "worse than carbon monoxide poisoning"; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (body aches) and NAUSEA (constant nausea "worse than carbon monoxide poisoning") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), MYALGIA (body aches) and NAUSEA (constant nausea "worse than carbon monoxide poisoning"). At the time of the report, CHILLS (chills), MYALGIA (body aches) and NAUSEA (constant nausea "worse than carbon monoxide poisoning") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications are provided.   Reporter did not allow further contact
From the moment I was injected I felt a sharp shooting pain from the injection site down to my elbow. This was constant for about 2 weeks and up until now it is frequent with some intermittent relief. It is a deep pain that still radiates the entire upper portion of my injected arm (left arm).. at this point, I am unsure if this could be permanent and result in testing.
I had a sore throat, severe headache, nausea, body aches, and a 101 fever.  I followed up with my family physician and the health department.  I was told to go to the emergency room if symptoms became any more severe.
tiredness, light-headed, chest pain, head-ache with dizziness upon walking, stomach ache.
Hot to touch; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch) and VACCINATION SITE PRURITUS (Itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot to touch) and VACCINATION SITE PRURITUS (Itching). At the time of the report, VACCINATION SITE WARMTH (Hot to touch) and VACCINATION SITE PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Patient presented with trouble breathing and rapid heartbeat ten minutes after the vaccine was administered , rescue squad was contacted and they arrived about 30 minutes later. She continued to experience symptoms  until they arrived and they took to er for observation  for about and hour. Decided may have been anxiety attack as she was only observed and then released when she felt fine again
AFIB noticed 8/10/2021 when running a EKG before my cataract surgery.
BREAKTHROUGH INFECTION; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a parent via a company representative via social media concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced breakthrough infection and had almost no symptoms and suspected clinical vaccination failure. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the breakthrough infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220100161-Covid-19 vaccine ad26.cov2.s- Breakthrough infection. This event(s) is considered unassessable. The event(s) has unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  20220100161-covid-19 vaccine ad26.cov2.s- Suspected clinical Vaccination failure. This event is considered not related. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
24 hours after receiving vaccine, developed redness, swelling tracking distally from site of vaccination. No fever or vesicular eruption.
Inadequate dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INCORRECT DOSE ADMINISTERED (Inadequate dose) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Inadequate dose). At the time of the report, INCORRECT DOSE ADMINISTERED (Inadequate dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antibody test: negative (Negative) Negative.         Patient had no adverse events after both doses.  No concomitant medications were provided by the reporter.  No Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow-up information received on 23-Jul-2021 contains updated information of second dose and first and second dose outcomes.
This spontaneous report was received from a registered nurse concerning a 17 years-old patient of an unknown gender. The patient's history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 20-SEP-2016, the patient was vaccinated intramuscularly with GARDASIL 9 first dose and another dose of it was administered later on 26-OCT-2016 (lot #, expiration date, strength and dose were not reported). It was reported that the patient received the third intramuscular dose of GARDASIL 9 with lot # M016193 and expiration date of 24-APR-2018 (strength and dose were not reported) on "either 22-NOV-2016 or 23-NOV-2016". No side effects were reported. No further information was available. No product quality complain (PQC) was involved. Additional information has been requested.
pregnant 16 year old pediatric patient at 20 weeks and 3 days gestation; given Fluarix on 10/14/2021 and then given FluLaval on 10/18/2021; pregnant 16 year old pediatric patient at 20 weeks and 3 days gestation; This prospective pregnancy case was reported by a nurse via call center representative and described the occurrence of vaccine exposure during pregnancy in a 15-year-old female patient who received Flu Seasonal QIV (FluLaval Quadrivalent 2021-2022 season) (batch number 24BM2, expiry date unknown) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 7LX9G, expiry date unknown) for prophylaxis and flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 18th October 2021, the patient received FluLaval Quadrivalent 2021-2022 season. On 14th October 2021, the patient received Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. The patient's last menstrual period was on an unknown date and estimated date of delivery was on an unknown date. The patient received FluLaval Quadrivalent 2021-2022 season at an unknown time during the pregnancy. On 14th October 2021, not applicable after receiving FluLaval Quadrivalent 2021-2022 season and unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced vaccine exposure during pregnancy. On 18th October 2021, the patient experienced vaccine exposure during pregnancy and extra dose administered. On an unknown date, the outcome of the vaccine exposure during pregnancy, vaccine exposure during pregnancy and extra dose administered were unknown. The pregnancy was ongoing.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: At the time of reporting the patient's age was 16 years. The nurse reported that pregnant pediatric patient at 20 weeks and 3 days gestation received Fluarix and FluLaval, which led to vaccine exposure during pregnancy. The patient received FluLaval quadrivalent 4 days apart after Fluarix, which led to extra dose administered. The reporter consented to follow up.
Headache, SkinRash & Diarrhea Received 2nd vaccine 0920 on 3/23/21. Face started to itch within a few minutes of receiving vaccine. Whole body started itching all over, took some benadryl and itching got worse, has diarrhea, and headache. Went to Urgent care for antihistamine (benadryl and formadine)
pain in the back; She is feeling tired, being light headed; her legs also have muscular pain; She is feeling tired, being light headed; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A female patient of unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: not reported) via unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she experienced side effects today w/c was 6 days after the 2nd dose. The patient stated that she was feeling tired, being lightheaded, pain in the back and her legs also have muscular pain. The patient wanted to know if it was normal to have them. The outcome of the events was unknown.  Information on the lot/batch number has been requested. The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Moderna booster was accidentally administered too soon, 2 months after 2nd Moderna dose instead of 5 months after 2nd dose. We had initially believed we were administering a 2nd Moderna dose and not a booster, but found out this week that the same client's first dose was under a separate profile in system.
Narrative: Patient reports injection site pain for one day after vaccination.  Other Relevant Hx: Symptoms: & injection site reaction Treatment:
After leaving facility,  lips were tingling and tongue felt swelling.  Little chest pain.  Got home and took 2 Benadryl.  Symptoms stopped in about 20 min.
I had an episode of irregular heartbeat and atrial fibrillation that lasted for approximately 3 hours the day after receiving the Pfizer Covid-19 booster. I was wearing a heart monitor at the time and this event precipitated a call from the doctor's office, wanting to put me on a calcium channel blocker and blood thinner. I told them this was related to the vaccine booster but the doctor doesn't believe that. I disagree so I am reporting it. I wore the monitor for 3 weeks and this was the only afib event. It resolved itself the same day.
SYMPTOMS BEGAN ON 11/12/2021 AT APPROX 11:35AM.  FEVER 102.7 NAUSEA. MALAISE AND FATIGURE.  EPISODES OF HYPOXIA
Resident went into respiratory distress during early am of 6/7/2021.  Pulse ox dropped to 56%.  Resident sent to Medical Center and admitted with Respiratory Failure.
sneezing, stuffy nose, facial pain, coughing, entire body ache/pain, sore right arm,  headache, foggy
I got my booster, then a few days later I got Covid-19. I had symptoms for a few days then they cleared up. A few days after my symptoms cleared up I broke out in hives. I am still dealing with my hives and taking allergy medications when they get too itchy. I do not know if this is a Covid-19 side effect or a booster side effect. Its worth noting that with my first dose of the vaccine I got a rash all up my neck on the side of my body that received the vaccine. This cleared up after a few days.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 05-NOV-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB (exposed to the following temperatures and cumulative time frames colder than 36F: In September of 2015, the coldest temperature was 34F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34F for 192 hours, for a total of 1,031.3 hours (43 days)) with lot number: L010595, expiry date: 12-NOV-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
fever, chills, body aches, nausea, fatigue, pain , swelling, red rash at injection site.
1st dose 2 years ago, has not received the 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received over 2 years before the reporting date).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 29-MAR-2022 Reporter's Comments: The exact date of first dose, lot number, and expiration date was not available to the pharmacist as the patient was not in their system and received the first dose at a different facility.   The pharmacist reported patient came into pharmacy stating she had her first dose of Shingrix series over 2 years prior to the reporting and had not yet received the second dose, which led to incomplete course of vaccination. The pharmacist gave permission for follow-up.
High pitched ringing in ears. I noticed about 1-2 weeks after 2nd dose. I have not seen a doctor about it yet
I24.8 DEMAND ISCHEMIA 4/8/2023 CHRONIC PAIN I24.8 DEMAND ISCHEMIA 4/8/2023 HEMOCHROMATOSIS I24.8 DEMAND ISCHEMIA 4/8/2023 ANEMIA
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 47-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided.  Reporter stated that no treatment was given to the patient.  Reporter also stated that the vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
Tinnitus  mostly in my left ear.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 16Mar2021 07:30 (Batch/Lot number: unknown) at the age of 58 years as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ZOLOFT; WELLBUTRIN. Past drug history included: Gentamicin, reaction(s): "known allergies: Gentamicin".  The following information was reported: TINNITUS (non-serious) with onset 18Mar2021, outcome "not recovered", described as "Tinnitus  mostly in my left ear.". Therapeutic measures were not taken as a result of tinnitus.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.